Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states

Eye & Contact Lens
Hugo Y HsuHeidi A Israel

Abstract

To evaluate the ophthalmic community's current opinions of the management of bacterial keratitis and usage of the currently available ophthalmic antibiotics. An anonymous questionnaire was mailed to ophthalmologists in California, Florida, Illinois, and Missouri. The results were tabulated and analyzed statistically. Six hundred twenty-nine usable questionnaires (10.3%) were returned. In the management of corneal ulcers, 42.2% of comprehensive ophthalmologists and 75.3% of cornea specialists perform Gram stains some of the time. A total of 73.3% of comprehensive ophthalmologists and 93.7% of cornea specialists perform corneal cultures some of the time. A total of 88.8% of comprehensive ophthalmologists and 76% of cornea specialists initiate treatment with the newer fluoroquinolone antibiotics. A total of 12.1% of comprehensive ophthalmologists and 41% of cornea specialists would select fortified antibiotics for the treatment of corneal ulcers. The percentage of those who feel that fortified antibiotics are superior ranges from 17.7% for comprehensive ophthalmologists to 33.3% for cornea specialists. A total of 65.7% of comprehensive ophthalmologists indicate that the newer fluoroquinolones have impacted their practices, and 58....Continue Reading

References

Nov 15, 1992·American Journal of Ophthalmology·P J McDonnellM Trousdale
Nov 15, 1992·American Journal of Ophthalmology·J S Pepose, K R Wilhelmus
Apr 1, 1997·Archives of Ophthalmology·V O KowalE J Cohen
Jul 16, 1999·Ophthalmology·M H GoldsteinY J Gordon
Apr 5, 2002·American Journal of Ophthalmology·Rookaya MatherRegis P Kowalski
Mar 15, 2003·European Journal of Ophthalmology·N M PharmakakisJ X Koliopoulos
Apr 10, 2003·Ophthalmology Clinics of North America·Francis S Mah
Aug 21, 2003·The British Journal of Ophthalmology·M DaniellN Morlet
Mar 5, 2005·Nature Medicine
Aug 1, 2006·American Journal of Ophthalmology·Charlotte E JoslinJoel Sugar
Aug 24, 2006·JAMA : the Journal of the American Medical Association·Douglas C ChangUNKNOWN Fusarium Keratitis Investigation Team

❮ Previous
Next ❯

Citations

Oct 12, 2011·Archives of Ophthalmology·Muthiah SrinivasanUNKNOWN Steroids for Corneal Ulcers Trial Group
Mar 27, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Prajna LalithaThomas M Lietman
Jul 22, 2011·Cornea·Jamie B Rosenberg, David C Gritz
Feb 28, 2013·Expert Opinion on Pharmacotherapy·Darlene Miller
May 12, 2015·Peptides·Maria Luisa MangoniAlison M McDermott
Jun 26, 2013·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Sanjeev Y TuliSonal S Tuli
May 15, 2013·Ophthalmic Epidemiology·Catherine E OldenburgNisha R Acharya
Dec 24, 2014·Eye & Contact Lens·Jennifer ParkDavid C Gritz
Nov 29, 2016·PloS One·Michael PolitisAbraham Solomon
Mar 17, 2017·The British Journal of Ophthalmology·Julia Dutra RossettoOriel Spierer
Dec 12, 2017·BMJ Open Ophthalmology·Ariana AustinJennifer Rose-Nussbaumer
Aug 24, 2019·Eye & Contact Lens·Lisa BennettSean L Edelstein
Oct 21, 2017·Cornea·Michelle Y PengJennifer Rose-Nussbaumer
Aug 31, 2021·The Ocular Surface·Lawson Ung, James Chodosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.